The abundance of Pseudomonas bacteria and related virulence factors in the lungs of people with cystic fibrosis (CF) after…
Articles by Andrea Lobo, PhD
The 10th Annual Glow Ride for Cystic Fibrosis (CF), held Sept. 21 at Hermosa Beach, California, exceeded expectations by…
An agency of the National Institutes of Health has awarded funding up to $7 million to researchers at the University…
Lung function decline slowed consistently over five years with Kalydeco (ivacaftor) treatment in adults and children with cystic…
More severe lung disease and using inhaled corticosteroids are associated with shorter telomere length, a sign of cellular aging, in…
Most people with cystic fibrosis (CF) who carry mutations that make them ineligible for CFTR modulators are prescribed medications…
Having COVID-19 had no clinically meaningful impact on lung function and nutritional status for people with cystic fibrosis in…
The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial testing ARCT-032, an inhaled therapy candidate,…
A report described episodes of skin rash associated with joint pain and inflammation, known as dermatitis-arthritis syndrome, in four females…
A researcher at the University of California, Los Angeles (UCLA) has been awarded the Elizabeth Nash Postdoctoral Fellowship to…